Thane Wettig

Insider Reports History

Location
San Francisco, CA
Signature
/s/ John Alden, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thane Wettig:

Company Role Class Num Shares Value Price $ Report Date Ownership
FIBROGEN INC CEO, Director Common Stock 24,680 $207,805 $8.42 06 Dec 2025 Direct
FIBROGEN INC CEO, Director Common Stock 40 $397 $9.94 06 Dec 2025 By spouse
KYNTRA BIO, INC. CEO, Director Stock Option (Right to Buy) 60,000 03 Feb 2026 Direct

Insider Reports Filed by Thane Wettig

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KYNB KYNTRA BIO, INC. 03 Feb 2026 1 $0 4 CEO, Director 05 Feb 2026, 21:08
FGEN FIBROGEN INC 06 Dec 2025 1 -$2,181 4 CEO, Director 09 Dec 2025, 16:10
FGEN FIBROGEN INC 13 Nov 2025 2 +$33,750 4 CEO, Director 17 Nov 2025, 16:42
FGEN FIBROGEN INC 06 Jun 2025 2 -$4,928 4 CEO, Director 09 Sep 2025, 19:25
FGEN FIBROGEN INC 24 Mar 2025 1 +$50,663 4 CEO, Director 25 Mar 2025, 09:00
FGEN FIBROGEN INC 06 Mar 2025 3 -$8,738 4 CEO, Director 07 Mar 2025, 19:03
FGEN FIBROGEN INC 09 Jan 2025 1 $0 4 CEO, Director 10 Jan 2025, 18:15
FGEN FIBROGEN INC 06 Dec 2024 1 -$808 4 CEO, Director 09 Dec 2024, 20:00
FGEN FIBROGEN INC 06 Sep 2024 1 -$922 4 CEO, Director 09 Sep 2024, 20:00
FGEN FIBROGEN INC 01 Aug 2024 1 -$9,795 4 CEO, Director 05 Aug 2024, 16:18
FGEN FIBROGEN INC 22 Jun 2024 1 -$884 4 CEO, Director 25 Jun 2024, 16:30
FGEN FIBROGEN INC 06 Jun 2024 1 -$2,683 4 CEO, Director 07 Jun 2024, 19:00
FGEN FIBROGEN INC 01 May 2024 1 -$24,383 4 CEO, Director 02 May 2024, 19:46
FGEN FIBROGEN INC 22 Mar 2024 1 -$2,018 4 CEO, Director 25 Mar 2024, 17:58
FGEN FIBROGEN INC 07 Mar 2024 1 +$95,470 4 CEO 11 Mar 2024, 19:06
FGEN FIBROGEN INC 06 Mar 2024 3 -$8,480 4 CEO 08 Mar 2024, 19:18
FGEN FIBROGEN INC 21 Feb 2024 2 $0 4 CEO 23 Feb 2024, 20:33
FGEN FIBROGEN INC 01 Feb 2024 1 -$55,671 4 CEO 05 Feb 2024, 20:08
FGEN FIBROGEN INC 22 Dec 2023 1 -$622 4 CEO 26 Dec 2023, 19:28
FGEN FIBROGEN INC 06 Dec 2023 1 -$974 4 CEO 11 Dec 2023, 16:19
FGEN FIBROGEN INC 01 Nov 2023 1 -$11,949 4 CEO 03 Nov 2023, 16:20
FGEN FIBROGEN INC 22 Sep 2023 1 -$644 4 Interim CEO 25 Sep 2023, 19:37
FGEN FIBROGEN INC 06 Sep 2023 1 -$1,618 4 Interim CEO 08 Sep 2023, 17:00
FGEN FIBROGEN INC 07 Aug 2023 2 $0 4 Chief Commercial Officer 09 Aug 2023, 17:28
FGEN FIBROGEN INC 23 Jun 2023 1 -$13,075 4 Chief Commercial Officer 26 Jun 2023, 16:27
FGEN FIBROGEN INC 07 Jun 2023 2 -$29,951 4/A Chief Commercial Officer 22 Jun 2023, 18:32
FGEN FIBROGEN INC 23 Mar 2023 1 -$16,933 4 Chief Commercial Officer 24 Mar 2023, 20:27
FGEN FIBROGEN INC 20 Mar 2023 2 $0 4 Chief Commercial Officer 29 Mar 2023, 17:05
FGEN FIBROGEN INC 08 Mar 2023 5 -$287,435 4 Chief Commercial Officer 10 Mar 2023, 20:53
FGEN FIBROGEN INC 21 Feb 2023 2 $0 4 Chief Commercial Officer 23 Feb 2023, 19:42
FGEN FIBROGEN INC 31 Dec 2022 2 $0 5/A Chief Commercial Officer 17 Feb 2023, 16:26
FGEN FIBROGEN INC 23 Dec 2022 1 -$11,597 4 Chief Commercial Officer 28 Dec 2022, 17:38
FGEN FIBROGEN INC 08 Dec 2022 1 -$6,032 4 Chief Commercial Officer 09 Dec 2022, 18:21
FGEN FIBROGEN INC 22 Sep 2022 1 -$8,030 4 Chief Commercial Officer 26 Sep 2022, 16:27
FGEN FIBROGEN INC 06 Sep 2022 1 -$4,414 4 Chief Commercial Officer 08 Sep 2022, 18:54
FGEN FIBROGEN INC 22 Jun 2022 1 -$7,480 4 Chief Commercial Officer 24 Jun 2022, 17:27
FGEN FIBROGEN INC 06 Jun 2022 1 -$3,420 4 Chief Commercial Officer 08 Jun 2022, 19:22
FGEN FIBROGEN INC 22 Mar 2022 1 -$8,718 4 Chief Commercial Officer 24 Mar 2022, 19:57
FGEN FIBROGEN INC 07 Mar 2022 1 -$21,649 4 Chief Commercial Officer 09 Mar 2022, 16:46
FGEN FIBROGEN INC 14 Feb 2022 2 $0 4 Chief Commercial Officer 16 Feb 2022, 20:05
FGEN FIBROGEN INC 22 Dec 2021 1 -$7,739 4 Chief Commercial Officer 23 Dec 2021, 16:17
FGEN FIBROGEN INC 22 Sep 2021 1 -$6,312 4 Chief Commercial Officer 24 Sep 2021, 16:02
FGEN FIBROGEN INC 26 Aug 2021 1 +$35,743 4 Chief Commercial Officer 30 Aug 2021, 20:11
FGEN FIBROGEN INC 22 Jun 2021 1 -$71,696 4 Chief Commercial Officer 24 Jun 2021, 19:27